Latest Breaking News On - Drugs group - Page 7 : comparemela.com

IPHA accepts rollover extending four year supply agreement for medicines during pandemic Patients are to get access to more of the latest treatment options following the release of an estimated €30 million aimed at clearing a ‘backlog’ of new medicines, according to the Irish Pharmaceutical Healthcare Association (IPHA). The move comes in addition to the industry agreeing to roll over an extension to the existing four-year supply Agreement with the State. The 15 ‘backlogged’ new medicines are to treat patients with a range of diseases, including lung cancer, renal cell carcinoma, urethral carcinoma, leukaemia, Parkinson’s disease and chronic migraine. A number of the medicines have already been approved by the Executive Management Team of the Health Service Executive (HSE). The HSE is planning their rollout.

Ireland
Irish
Oliver-oconnor
Paul-reid
Management-team-of-the-health-service-executive
Irish-pharmaceutical-healthcare-association
Drugs-group
Executive-management-team
Health-service-executive
Chief-executive
ஐயர்ல்யாஂட்
ஐரிஷ்